Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06377527 | RECRUITING | Mesonephric-like Adenocarcinoma

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
Sponsor:

M.D. Anderson Cancer Center

Brief Summary:

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Condition or disease

Mesonephric-like Adenocarcinoma

Detailed Description:

Primary Objectives 1. To collect, both prospectively and retrospectively, data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA). Secondary Objectives 1. To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome. 2. To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.

Study Type : OBSERVATIONAL
Estimated Enrollment : 2000 participants
Official Title : Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
Actual Study Start Date : 2024-07-10
Estimated Primary Completion Date : 2035-12-28
Estimated Study Completion Date : 2037-12-28

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Adult patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA).
  • 2. Patients can also be diagnosed with mesonephric adenocarcinoma (MA) or patients with mesonephric and mesonephric-like carcinosarcomas.
  • 3. Patients who are receiving or have received treatment at any facility, including but not limited to MD Anderson Cancer Center are eligible.
  • 4. Patients may be residents of any country and be of any ethnic background.
  • 5. Patients who request to participate in the registry, regardless of the method by which they learned of it, are eligible to participate.
  • 6. Patients who do not speak English can be eligible if accompanied by an institutional interpreter.
Exclusion Criteria
  • 1. Patients with other subtypes of EACs.
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Location Details

NCT06377527

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Texas

MD Anderson Cancer Center

Houston, Texas, United States, 77030